within Pharmacolibrary.Drugs.ATC.M;

model M03CA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 3.833333333333334e-06,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0015833333333333333,
    Tlag           = 0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M03CA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dantrolene is a muscle relaxant primarily used to treat malignant hyperthermia, a life-threatening reaction to certain anesthesia drugs. It is also used in chronic spasticity related to upper motor neuron disorders such as cerebral palsy, stroke, multiple sclerosis, and spinal cord injury. Dantrolene acts on the ryanodine receptor to inhibit calcium release from the sarcoplasmic reticulum in skeletal muscle. It is approved and used clinically today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following oral administration in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Kambayashi, A, &amp; Dressman, JB (2017). Forecasting gastrointestinal precipitation and oral pharmacokinetics of dantrolene in dogs using an in vitro precipitation testing coupled with in silico modeling and simulation. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 119 107–113. DOI:<a href=\"https://doi.org/10.1016/j.ejpb.2017.06.012\">10.1016/j.ejpb.2017.06.012</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28619610/\">https://pubmed.ncbi.nlm.nih.gov/28619610</a></p></li><li><p>Haraschak, JL, et al., &amp; Archer, T (2014). Pharmacokinetic evaluation of oral dantrolene in the dog. <i>Journal of veterinary pharmacology and therapeutics</i> 37(3) 286–294. DOI:<a href=\"https://doi.org/10.1111/jvp.12089\">10.1111/jvp.12089</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24219828/\">https://pubmed.ncbi.nlm.nih.gov/24219828</a></p></li><li><p>DiMaio Knych, HK, et al., &amp; Stanley, SD (2011). Pharmacokinetics and metabolism of dantrolene in horses. <i>Journal of veterinary pharmacology and therapeutics</i> 34(3) 238–246. DOI:<a href=\"https://doi.org/10.1111/j.1365-2885.2010.01214.x\">10.1111/j.1365-2885.2010.01214.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21492188/\">https://pubmed.ncbi.nlm.nih.gov/21492188</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M03CA01;
